Sayed Ala Moududee

Dr. Sayed Ala Moududee

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
GNGilbert Nshogoza
Gilbert Nshogoza
YLYaqian Liu
Yaqian Liu
JGJia Gao
Jia Gao
MLMingqing Liu
Mingqing Liu
SMSayed Ala Moududee
Sayed Ala Moududee
KRKe Ruan
Ke Ruan
The TDP-43 is originally a nuclear protein but translocates to the cytoplasm in the pathological condition. TDP-43, as an RNA-binding protein, consists of two RNA Recognition Motifs (RRM1 and RRM2). RRMs are known to involve both protein-nucleotide and protein-protein interactions and mediate the formation of stress granules. Thus, they assist the entire TDP-43 protein with participating in neurodegenerative and cancer diseases. Consequently, they are potential therapeutic targets. Protein-observed and ligand-observed nuclear magnetic resonance (NMR) spectroscopy were used to uncover the small molecule inhibitors against the tandem RRM of TDP-43. We identified three hits weakly binding the tandem RRMs using the ligand-observed NMR fragment-based screening. The binding topology of these hits is then depicted by chemical shift perturbations (CSP) of the 15N-labeled tandem RRM and RRM2, respectively, and modeled by the CSP-guided High Ambiguity Driven biomolecular DOCKing (HADDOCK). These hits mainly bind to the RRM2 domain, which suggests the druggability of the RRM2 domain of TDP-43. These hits also facilitate further studies regarding the hit-to-lead evolution against the TDP-43 RRM domain.

1 October 2018 in Acta Crystallographica Section D Structural Biology
Verified
Journal Article
Closed access
PDF file
CXChanglin Xie
Changlin Xie
CHChao He
Chao He
YJYiyang Jiang
Yiyang Jiang
HYHailong Yu
Hailong Yu
LCLin Cheng
Lin Cheng
FLFudong Li
Fudong Li